Life · 3 authors, 3 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This narrative review outlines the treatment algorithm for benign prostatic obstruction, ranging from medical therapies to various surgical techniques, emphasizing that the choice depends on prostate size, patient symptoms, preference, and resources.
This narrative review provides an overview of the current treatment algorithm for managing benign prostatic obstruction (BPO). It discusses a comprehensive diagnostic assessment and a spectrum of treatments, from lifestyle modifications and medical therapy (including alpha-blockers, 5-alpha-reductase inhibitors, and supplements like saw palmetto) to surgical options such as transurethral resection of the prostate (TURP) and various minimally invasive surgical therapies (MIST). The review highlights that TURP is the established surgical standard, while newer techniques like laser therapies (e.g., HoLEP, PVP), aquablation, prostatic urethral lift, and prostate artery embolization offer alternatives with different risk-benefit profiles. The central conclusion is that treatment selection must be individualized, considering patient preferences, anatomical factors, availability of resources, and treatment goals.
